A miR-199a/miR-214 self-regulatory network via PSMD10, TP53 and DNMT1 in testicular germ cell tumor

Scientific Reports

Volumn 4, Issue , 2014, Pages

  Chen, Bi Feng ^a,b   Suen, Yick Keung ^a   Gu, Shen ^a   Li, Lu ^a   Chan, Wai Yee ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b WUHAN UNIVERSITY OF TECHNOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

DNA (CYTOSINE 5) METHYLTRANSFERASE; DNA (CYTOSINE-5-)-METHYLTRANSFERASE 1; MESSENGER RNA; MICRORNA; MIRN199 MICRORNA, HUMAN; MIRN214 MICRORNA, HUMAN; ONCOPROTEIN; PROTEASOME; PROTEIN P53; PSMD10 PROTEIN, HUMAN; TP53 PROTEIN, HUMAN;

ANTAGONISTS AND INHIBITORS; COMPARATIVE STUDY; DNA METHYLATION; GENE EXPRESSION REGULATION; GENETICS; HUMAN; MALE; METABOLISM; NEOPLASM; PROMOTER REGION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TESTIS; TESTIS TUMOR; TUMOR CELL CULTURE; WESTERN BLOTTING;

BLOTTING, WESTERN; DNA (CYTOSINE-5-)-METHYLTRANSFERASE; DNA METHYLATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MICRORNAS; NEOPLASMS, GERM CELL AND EMBRYONAL; PROMOTER REGIONS, GENETIC; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTO-ONCOGENE PROTEINS; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TESTICULAR NEOPLASMS; TESTIS; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84923312315     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep06413     Document Type: Article

References (53)

1. Chen, C. Z. MicroRNAs as oncogenes and tumor suppressors. N Engl J Med 353, 1768-1771 (2005).
2. Baylin, S. B. DNA methylation and gene silencing in cancer. Nat Clin Pract Oncol 2 Suppl 1, S4-11 (2005).
3. Li, W. & Chen, B. F. Aberrant DNA methylation in human cancers. J Huazhong Univ Sci Technolog Med Sci 33, 798-804 (2013).
4. Lechner, M., Boshoff, C. & Beck, S. Cancer epigenome. Adv Genet 70, 247-276 (2010).
5. Chen, B. F. & Chan, W. Y. The de novo DNA methyltransferase DNMT3A in development and cancer. Epigenetics 9, 669-677 (2014).
6. Gilbert, D., Rapley, E. & Shipley, J. Testicular germ cell tumours: predisposition genes and the male germ cell niche. Nat Rev Cancer 11, 278-288 (2011).
7. Bosl, G. J. &Motzer, R. J. Testicular germ-cell cancer. N Engl J Med 337, 242-253 (1997).
8. Oosterhuis, J. W. & Looijenga, L. H. Testicular germ-cell tumours in a broader perspective. Nat Rev Cancer 5, 210-222 (2005).
9. Burger, H., Nooter, K., Boersma, A.W.M., Kortland, C. J. & Stoter, G. Expression of p53, Bcl-2 and Bax in cisplatin-induced apoptosis in testicular germ cell tumour cell lines. Br J Cancer 77, 1562-1567 (1998).
10. Koch, S., Mayer, F., Honecker, F., Schittenhelm, M. & Bokemeyer, C. Efficacy of cytotoxic agents used in the treatment of testicular germ cell tumours under normoxic and hypoxic conditions in vitro. Br J Cancer 89, 2133-2139 (2003).
11. Skotheim, R. I. et al. Differentiation of human embryonal carcinomas in vitro and in vivo reveals expression profiles relevant to normal development. Cancer Res 65, 5588-5598 (2005).
12. Cheung, H. H. et al. Genome-wide DNA methylation profiling reveals novel epigenetically regulated genes and non-coding RNAs in human testicular cancer. Br J Cancer 102, 419-427 (2010).
13. Gu, S. et al. Molecular mechanisms of regulation and action of microRNA-199a in testicular germ cell tumor and glioblastomas. PLoS One 8, e83980 (2013).
14. Cheung, H. H. et al. Methylation of an intronic region regulates miR-199a in testicular tumor malignancy. Oncogene 30, 3404-3415 (2011).
15. Chen, B. F., Gu, S., Suen, Y. K., Li, L. & Chan, W. Y. microRNA-199a-3p, DNMT3A, and aberrant DNA methylation in testicular cancer. Epigenetics 9, 119-128 (2014).
16. He, J. et al. Reactive oxygen species regulate ERBB2 and ERBB3 expression via miR-199a/125b and DNA methylation. EMBO Rep 13, 1116-1122 (2012).
17. Lee, Y. B. et al. Twist-1 regulates the miR-199a/214 cluster during development. Nucleic Acids Res 37, 123-128 (2009).
18. Sakurai, K. et al. MicroRNAs miR-199a-5p and -3p target the Brm subunit of SWI/ SNF to generate a double-negative feedback loop in a variety of human cancers. Cancer Res 71, 1680-1689 (2011).
19. Wienholds, E. et al. MicroRNA expression in zebrafish embryonic development. Science 309, 310-311 (2005).
20. Yi, R. et al. Morphogenesis in skin is governed by discrete sets of differentially expressed microRNAs. Nat Genet 38, 356-362 (2006).
21. van Rooij, E. et al. A signature pattern of stress-responsive microRNAs that can evoke cardiac hypertrophy and heart failure. Proc Natl Acad Sci U S A 103, 18255-18260 (2006).
22. Fischer, L. et al. Differential micro-RNA expression in primary CNS and nodal diffuse large B-cell lymphomas. Neuro Oncol 13, 1090-1098 (2011).
23. Santhakumar, D. et al. Combined agonist-antagonist genome-wide functional screening identifies broadly active antiviral microRNAs. Proc Natl Acad Sci U S A 107, 13830-13835 (2010).
24. Lin, R. K. et al. Dysregulation of p53/Sp1 control leads toDNA methyltransferase- 1 overexpression in lung cancer. Cancer Res 70, 5807-5817 (2010).
25. Kwok. HPV-16 E6 upregulation of DNMT1 through repression of tumor suppressor p53. Oncol Rep 24, 1599-1604 (2010).
26. Cheng, J. C., Auersperg, N. & Leung, P. C. Inhibition of p53 represses E-cadherin expression by increasing DNA methyltransferase-1 and promoter methylation in serous borderline ovarian tumor cells. Oncogene 30, 3930-3942 (2011).
27. Cheng, J. C., Auersperg, N. & Leung, P. C. Inhibition of p53 induces invasion of serous borderline ovarian tumor cells by accentuating PI3K/Akt-mediated suppression of E-cadherin. Oncogene 30, 1020-1031 (2011).
28. Misiewicz-Krzeminska, I. et al. Restoration of microRNA-214 expression reduces growth of myeloma cells through positive regulation of P53 and inhibition of DNA replication. Haematologica 98, 640-648 (2013).
29. Qiu, W. et al. Retinoblastoma protein modulates gankyrin-MDM2 in regulation of p53 stability and chemosensitivity in cancer cells. Oncogene 27, 4034-4043 (2008).
30. Bauer, S. et al. Therapeutic potential of Mdm2 inhibition in malignant germ cell tumours. Eur Urol 57, 679-687 (2010).
31. Kersemaekers, A. M. et al. Role of P53 and MDM2 in treatment response of human germ cell tumors. J Clin Oncol 20, 1551-1561 (2002).
32. Omisanjo, O. A. et al. DNMT1 and HDAC1 gene expression in impaired spermatogenesis and testicular cancer. Histochem Cell Biol 127, 175-181 (2007).
33. Antequera, F. Structure, function and evolution of CpG island promoters. Cell Mol Life Sci 60, 1647-1658 (2003).
34. Leu, Y. W. et al. Double RNA interference of DNMT3b and DNMT1 enhances DNA demethylation and gene reactivation. Cancer Res 63, 6110-6115 (2003).
35. Vare, P. & Soini, Y. Twist is inversely associated with claudins in germ cell tumors of the testis. Apmis 118, 640-647 (2010).
36. Sun, X., Guo, J. H., Chen, H., Ruan, Y. C. & Chan, H. C. Regulation of miR101/ miR-199a-3p targeting cyclooxygenase-2 by the epithelial sodium channel during embryo implantation (911.5). FASEB J 28 (2014).
37. Siomi, H. & Siomi, M. C. Posttranscriptional regulation of microRNA biogenesis in animals. Mol Cell 38, 323-332 (2010).
38. Soto, A. M. & Sonnenschein, C. The somatic mutation theory of cancer: growing problems with the paradigm? Bioessays 26, 1097-1107 (2004).
39. Dawson, M. A., Kouzarides, T. & Huntly, B. J. Targeting epigenetic readers in cancer. N Engl J Med 367, 647-657 (2012).
40. Rodriguez-Paredes, M. & Esteller, M. Cancer epigenetics reaches mainstream oncology. Nat Med 17, 330-339 (2011).
41. Sharma, S., Kelly, T. K. & Jones, P. A. Epigenetics in cancer. Carcinogenesis 31, 27-36 (2010).
42. Xia, H., Ooi, L. L. & Hui, K. M. MiR-214 targets beta-catenin pathway to suppress invasion, stem-like traits and recurrence of human hepatocellular carcinoma. PLoS One 7, e44206 (2012).
43. Wang, X. J. et al. MiR-214 inhibits cell growth in hepatocellular carcinoma through suppression of beta-catenin. Biochem Biophys Res Commun 428, 525-531 (2012).
44. Chen, D. L. et al. Identification of miR-214 as a negative regulator of colorectal cancer liver metastasis via regulation of FGFR1 expression. Hepatology 60, 598-609 (2014).
45. Derfoul, A. et al. Decreased microRNA-214 levels in breast cancer cells coincides with increased cell proliferation, invasion and accumulation of the Polycomb Ezh2 methyltransferase. Carcinogenesis 32, 1607-1614 (2011).
46. Fischer, L. et al. Differential micro-RNA expression in primary CNS and nodal diffuse large B-cell lymphomas. Neuro Oncol 13, 1090-1098 (2011).
47. Sun, W., Julie Li, Y. S., Huang, H. D., Shyy, J. Y. & Chien, S. microRNA: a master regulator of cellular processes for bioengineering systems. Annu Rev Biomed Eng 12, 1-27 (2010).
48. Bushati, N. & Cohen, S. M. microRNA functions. Annu Rev Cell Dev Biol 23, 175-205 (2007).
49. Netto, G. J. et al. Global DNA hypomethylation in intratubular germ cell neoplasia and seminoma, but not in nonseminomatous male germ cell tumors. Mod Pathol 21, 1337-1344 (2008).
50. Minami, K. et al. DNMT3L Is a Novel Marker and Is Essential for the Growth of Human Embryonal Carcinoma. Clin Cancer Res 16, 2751-2759 (2010).
51. Arai, E., Nakagawa, T., Wakai-Ushijima, S., Fujimoto, H. & Kanai, Y. DNA methyltransferase 3B expression is associated with poor outcome of stage I testicular seminoma. Histopathology 60, E12-E18 (2012).
52. Chen, C. et al. Real-time quantification of microRNAs by stem-loop RT-PCR. Nucleic Acids Res 33, e179 (2005).
53. Herman, J.G., Graff, J. R., Myohanen, S., Nelkin, B. D. & Baylin, S. B. Methylationspecific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci U S A 93, 9821-9826 (1996).